Literature DB >> 3005378

Naloxone withdrawal exacerbates Tourette syndrome.

R Sandyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3005378     DOI： 10.1097/00004714-198602000-00029

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

Authors:  M Olga Rojas-Corrales; Juan Gibert-Rahola; Juan A Mico
Journal:  Psychopharmacology (Berl)       Date:  2006-11-11       Impact factor: 4.530

3.  Tourette syndrome: successful treatment with clonidine and oxycodone.

Authors:  R Sandyk
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.